CtDNA as a predictor of outcome in patients treated with neoadjuvant atezolizumab in muscle invasive urothelial cancer
Powles, T, Szabados, B, Castellano, D, Rodriguez-Vida, A, Valderrama, B, Crabb, S, Van Der Heijden, M, Pous, AF, Prendergast, A, Gravis, G, Herranz, UA, Sharma, S, Ravauld, A, Sethi, H, Zimmerman, B,Volume:
38
Journal:
Urologic Oncology: Seminars and Original Investigations
DOI:
10.1016/j.urolonc.2020.10.069
Date:
December, 2020
File:
PDF, 5.50 MB
2020